Emma Holian

410 total citations
16 papers, 281 citations indexed

About

Emma Holian is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Emma Holian has authored 16 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Emma Holian's work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (5 papers). Emma Holian is often cited by papers focused on MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (5 papers). Emma Holian collaborates with scholars based in Ireland and United Kingdom. Emma Holian's co-authors include Michael J. Kerin, James A. L. Brown, John Hinde, Norma Coffey, Róisín M. Dwyer, Aoïfe Lowery, John Newell, Nicola Miller, Ronan Waldron and Maccon Keane and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Emma Holian

16 papers receiving 271 citations

Peers

Emma Holian
Zhilin Jin United States
Youting Sun United States
Benjamin J. Lengerich United States
Xi-xi Li China
Guillermo E. Rivas United States
Qingxiang Yan United States
Kexin Lou China
Cleo Keppens Belgium
Zhilin Jin United States
Emma Holian
Citations per year, relative to Emma Holian Emma Holian (= 1×) peers Zhilin Jin

Countries citing papers authored by Emma Holian

Since Specialization
Citations

This map shows the geographic impact of Emma Holian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Holian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Holian more than expected).

Fields of papers citing papers by Emma Holian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Holian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Holian. The network helps show where Emma Holian may publish in the future.

Co-authorship network of co-authors of Emma Holian

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Holian. A scholar is included among the top collaborators of Emma Holian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Holian. Emma Holian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Davey, Matthew G., Heidi Annuk, Emma Holian, et al.. (2022). MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer. Cancers. 14(9). 2109–2109. 16 indexed citations
2.
Davey, Matthew G., Ronan Waldron, Emma Holian, et al.. (2022). Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer. Annals of Surgery. 276(5). 905–912. 22 indexed citations
3.
Davey, Matthew G., Heidi Annuk, Emma Holian, et al.. (2022). Identification of a Five-MiRNA Expression Assay to Aid Colorectal Cancer Diagnosis. SHILAP Revista de lepidopterología. 4(3). 190–204. 1 indexed citations
4.
Davey, Matthew G., Ronan Waldron, Emma Holian, et al.. (2022). Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial. Journal of the American College of Surgeons. 236(2). 317–327. 12 indexed citations
5.
King, Lydia, Andrew Flaus, Emma Holian, & Aaron Golden. (2021). Survival outcomes are associated with genomic instability in luminal breast cancers. PLoS ONE. 16(2). e0245042–e0245042. 8 indexed citations
6.
Holian, Emma, et al.. (2020). Assessment of groundwater processes using censored data analysis incorporating non-detect chemical, physical, and biological data. Journal of Contaminant Hydrology. 235. 103706–103706. 12 indexed citations
7.
Moloney, Brian, Katie Gilligan, Doireann Joyce, et al.. (2020). Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer. Cells. 9(1). 141–141. 24 indexed citations
8.
Waldron, Ronan, Helen Heneghan, Emma Holian, et al.. (2020). Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers. 12(7). 1820–1820. 31 indexed citations
9.
Arabkari, Vahid, Róisín M. Dwyer, Michael J. Kerin, et al.. (2019). Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer– A Comparison. Pathology & Oncology Research. 26(2). 833–844. 23 indexed citations
10.
Curran, Catherine, Mark Webber, Grace Callagy, et al.. (2019). Quantifying Tip60 (Kat5) stratifies breast cancer. Scientific Reports. 9(1). 3819–3819. 21 indexed citations
11.
Prakash, A, Emma Holian, Andrew McGuire, et al.. (2019). Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer. BMC Cancer. 19(1). 712–712. 28 indexed citations
12.
Holian, Emma, Alberto Alvarez‐Iglesias, Norma Bargary, et al.. (2018). Arsenic in Groundwater in South West Ireland: Occurrence, Controls, and Hydrochemistry. Frontiers in Environmental Science. 6. 10 indexed citations
13.
Holian, Emma, Catherine Curran, Carmel Malone, et al.. (2017). Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab. Breast Cancer Research and Treatment. 164(1). 221–229. 8 indexed citations
14.
Clancy, Cillian, Sonja Khan, Claire L. Glynn, et al.. (2016). Screening of exosomal microRNAs from colorectal cancer cells. Cancer Biomarkers. 17(4). 427–435. 32 indexed citations
15.
Joyce, Doireann, Claire L. Glynn, James A. L. Brown, et al.. (2015). Abstract P4-07-05: Exosome-mediated trafficking of microRNAs by breast cancer cells. Cancer Research. 75(9_Supplement). P4–7. 1 indexed citations
16.
Coffey, Norma, John Hinde, & Emma Holian. (2013). Clustering longitudinal profiles using P-splines and mixed effects models applied to time-course gene expression data. Computational Statistics & Data Analysis. 71. 14–29. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026